期刊文献+

HCCR-2干扰真核表达载体的构建及其稳定转染细胞系的建立 被引量:5

Construction of RNAi recombinant eukaryotic expression vectors of HCCR-2 and establishment of its stably transfected cell lines
下载PDF
导出
摘要 目的构建HCCR-2干扰真核表达载体,获得干扰质粒稳定转染的HepG2细胞系。方法人工合成HCCR-2基因干扰序列并定向插入到RNAi真核表达载体pGenesil-1,通过测序鉴定。将干扰质粒用脂质体法转染HepG2细胞,经G418持续压力选择和有限稀释法获得稳定转染的细胞系。RT-PCR检测筛选克隆HCCR-2 mRNA的表达水平。结果测序表明HCCR-2干扰序列及读框完全正确,干扰质粒稳定转染的HepG2细胞系在倒置荧光显微镜下呈绿色荧光。RT-PCR结果显示RNAi-H1、RNAi-H3序列对HCCR-2 mRNA有较好的抑制效果。结论成功构建了HCCR-2干扰真核表达载体,HCCR-2干扰质粒稳定转染的HepG2细胞系的建立为进一步研究HCCR-2在肝癌细胞中的作用奠定了基础。 Objective To construct the obtain the stabla transfected HepG2 cell lines. RNAI eukaryotic expression vectors of HCCR-2 and Methods Hairpin siRNA small interference RNA oligonucletides of HCCR-2 were chemically synthesized and inserted into pGenesil-1 vector after an- nealing, which were confirmed by sequencing, then the recombinant RNAi vectors were transfected into HepG2 cell by LipofectamineTM2000. Cells containing stable transformants were selected by the ability of resistance to G418 and isolated with a limited dilution, The mRNA expression of HC- CR-2 in the selected clones was detected by RT-PCR. Results Sequencing suggested that RNAi eukaryotic expression vectors targeting HCCR-2 possesse correct read frame and nucleotide se- quence, and green fluorescene of the stable transfected HepG2 cell lines could be observed under inverted fluorescence microscope. RT-PCR results showed that the sequence of RNAi-H1 and RNAi- H3 could effectively down-regulate the level of mRNA of HCCR-2. Conclusion RNAi eukaryotic expression vectors targeting HCCR-2 were successfully constructed and the establishment of stably transfected HepG2 cell lines laid a solid foundation for uncovering the mechanism of HCCR-2 in hepatocellular carcinoma cells.
出处 《实用临床医药杂志》 CAS 2008年第1期27-30,共4页 Journal of Clinical Medicine in Practice
基金 国家自然科学基金资助项目(3020012330570841)
关键词 HCCR-2 RNA干扰 稳定转染 HCCR-2 RNA interference stable transfection
  • 相关文献

参考文献16

  • 1Ko J, Lee Y H, Hwang S Y, et al. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 staloilization[J]. Oncogene, 2003, 22(30): 4679.
  • 2Chung Y J, Kim J W. Novel oncogene HCCR: its diagnostic and therapeutic implications for cancer [ J ]. Histol Histopathol, 2005, 20(3): 999.
  • 3Ko J, Shin S M, Oh Y M, et al. Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR-2 transgenic mice[J]. Oncogene, 2004, 23(10): 1950.
  • 4Jung S S, Park H S, Lee I J, et al. The HCCR oneoprotein as a biomarker for human breast cancer[J]. Clin Cancer Res, 2005, 11(21) : 7700.
  • 5Yoon S K, Lim N K, Ha S A, et al. The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma[J]. Cancer Res, 2004, 64(15) : 5434.
  • 6杨杨,张国新,施瑞华,林艳,郝波,王晓勇,王宏娣,黄祖瑚.人宫颈癌基因蛋白在人肝细胞癌中的表达及其临床意义[J].中华肝脏病杂志,2007,15(3):223-224. 被引量:21
  • 7郭军,房殿春,姜锋,杨仕明.人子宫颈癌基因HCCR-2真核表达载体的构建及鉴定[J].第四军医大学学报,2007,28(3):250-252. 被引量:1
  • 8Chakraborty C. Potentiality of small interfering RNAs (siRNA) as recent therapeutic targets for gene-silencing[J]. Curt Drug Targets, 2007, 8(3): 469.
  • 9Harley S A, Expanding the repertoire of RNA interference screens for developing new anticancer drug targets[J], Expert Ooin Ther Targets, 2007, 11(11) : 1429.
  • 10Li Y L, Quarles L D, Zhou H H, et al. RNA interference and its application in bone-related diseases[J ]. Biochem Biophys Res Commun, 2007, 361(4): 817.

二级参考文献10

  • 1林艳,杨杨,张国新,刘兵团,郝波,黄祖瑚.人HCCR蛋白表达载体的构建、表达及其蛋白纯化[J].南京医科大学学报(自然科学版),2006,26(9):757-760. 被引量:10
  • 2Ko J,Lee YH,Hwang SY,et al.Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization[J].Oncogene,2003,22(30):4679-4689.
  • 3Chung YJ,Kim JW.Novel oncogene HCCR:Its diagnostic and therapeutic implications for cancer[J].Histol Histopathol,2005,20(3):999-1003.
  • 4Ko J,Shin SM,Oh YM,et al.Transgenic mouse model for breast cancer:Induction of breast cancer in novel oncogene HCCR-2 transgenic mice[J].Oncogene,2004,23(10):1950-1953.
  • 5Yoon SK,Lim NK,Ha SA,et al.The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma[J].Cancer Res,2004,64(15):5434-5441.
  • 6Jung SS,Park HS,Lee IJ,et al.The HCCR:Oncoprotein as a biomarker for human breast cancer[J].Clin Cancer Res,2005,11(21):7700-7708.
  • 7Chung YJ,Kim JW.Novel oncogene HCCR:its diagnostic and therapeutic implications for cancer.Histol Histopathol,2005,20:999-1003.
  • 8Shin SM,Chung YJ,Oh ST,et al.HCCR-1 interacting molecule "deleted in polyposis 1"plays a tumor-suppressor role in colon carcinogenesis.Gastroenterology,2006,130:2074-2086.
  • 9Jung SS,Park HS,Lee IJ,et al.The HCCR oncoprotein as a biomarker for human breast cancer.Clin Cancer Res,2005,11:7700-7708.
  • 10Ko J,Shin SM,Oh YM,et al.Transgenic mouse model for breast cancer:induction of breast cancer in novel oncogene HCCR-2 transgenic mice.Oncogene,2004,23:1950-1953.

共引文献20

同被引文献48

  • 1孙梦宁,薛小平,尹文,吕欣,雷迎峰,韦三华,胡兴斌,杨敬.运用重叠PCR技术构建HCV全长cDNA细胞培养适应性突变体[J].生物技术通讯,2006,17(1):27-30. 被引量:4
  • 2杨杨,张国新,施瑞华,林艳,郝波,王晓勇,王宏娣,黄祖瑚.人宫颈癌基因蛋白在人肝细胞癌中的表达及其临床意义[J].中华肝脏病杂志,2007,15(3):223-224. 被引量:21
  • 3Chen G P, Shukeir N, Potti A, et al. Up-Regulation of wnt -1 and β- catenin production in patients with advanced metastatic prostate carcinoma[J]. CANCER, 2004, 101 (6) : 1345.
  • 4Wong S C, Lo S F, Lee K C, et al. Expression of frizzledrelated protein and wnt-signalling molecules in invasive human breast tumours[J]. J Pathol, 2002, 196(2) : 145.
  • 5Mikami I, Liang Y, Biao H. Efficacy of wnt-1 rnonoclonal antibody in sarcoma cells[J ]. BMC Cancer, 2005, 5 (1): 53.
  • 6You L, He B, Uematsu K, et al. Inhibition of wnt-1 signaling induces apoptosis in β-eatenin-deficient mesothelioma cells [J]. Cancer Res, 2004, 64(5): 3474.
  • 7Whangbo J S, Hunter C P. Environmental RNA interference [J]. Trends in Genetics, 2008, 24(6): 297.
  • 8Wieczorek M, Paczkowska A, Guzenda P. Silencing of wnt- 1 by siRNA induces apoptosis of MCF-7 human breast cancer cells[J]. Cancer Biol Ther, 2008, 7(2) : 275.
  • 9Polanee J, Z Pavelie P, Myers W L. Effect of wnt-1 anti- sense RNA on the outgrowth of a mammary adenocarcinoma cell line expressing that oncogene [ J ]. Clinical Molecular Pathology, 1996, 49(3): 166.
  • 10Fumi T Y, Toshiyuki S. The wnt/β-Catenin Signaling Pathway as a Target in Drug Discovery[J]. J Pha Sei, 2007, 104 (4) : 293.

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部